Log In
BCIQ
Print this Print this
 

hetIL-15

  Manage Alerts
Collapse Summary General Information
Company Admune Therapeutics LLC
DescriptionComplex of IL-15 with a cleaved soluble form of IL-15 receptor alpha chain (IL-15RA)
Molecular Target Interleukin-15 (IL-15)
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat metastic cancers
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/21/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today